Champions Oncology (CSBR) Total Current Liabilities (2011 - 2026)

Champions Oncology has reported Total Current Liabilities for 16 years, with the latest figure at $19.9 million in Q2 2026.

• On a quarterly basis, Total Current Liabilities fell 16.48% year-over-year to $19.9 million in Q2 2026; TTM through Apr 2026 was $19.9 million, a 16.48% decrease from a year earlier, with the FY2026 full-year figure at $19.9 million, down 16.48% from the prior year.
• Total Current Liabilities was $19.9 million for Q2 2026 at Champions Oncology, down from $20.7 million in the prior quarter.
• The five-year high for Total Current Liabilities was $23.9 million in Q2 2025, with the low at $15.5 million in Q1 2022.
• Average Total Current Liabilities over 5 years is $20.2 million, with a median of $20.5 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Total Current Liabilities surged 56.08% in 2022, then fell 16.48% in 2026.
• Over 5 years, Total Current Liabilities stood at $18.7 million in 2022, then climbed by 11.82% to $21.0 million in 2023, then dropped by 9.97% to $18.9 million in 2024, then rose by 17.39% to $22.1 million in 2025, then declined by 10.02% to $19.9 million in 2026.
• The last three Total Current Liabilities figures came in at $19.9 million (Q2 2026), $20.7 million (Q1 2026), and $22.1 million (Q4 2025), per Business Quant data.